Literature DB >> 11754991

The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases.

E G McGeer1, K Yasojima, C Schwab, P L McGeer.   

Abstract

Two short pentraxins, C-reactive protein and amyloid P, are found in association with the senile plaques and neurofibrillary tangles of Alzheimer disease (AD). Formerly thought to be made primarily if not solely in liver, recent work has shown that they are made not only in the brain but in other tissues such as heart and arteries. Their synthesis is markedly upregulated in affected brain regions in AD. Since they are known to activate the complement cascade in an antibody-independent fashion and chronic activation can cause destruction of host tissue, these pentraxins may be important initiators of an autodestructive process. As such, they may be prime targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754991     DOI: 10.1016/s0197-4580(01)00288-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

1.  Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease.

Authors:  Huan-Bing Lin; Xue-Mei Yang; Tie-Jun Li; Yu-Fang Cheng; Han-Ting Zhang; Jiang-Ping Xu
Journal:  Psychopharmacology (Berl)       Date:  2009-03-05       Impact factor: 4.530

2.  Late-onset Alzheimer's disease, heating up and foxed by several proteins: pathomolecular effects of the aging process.

Authors:  Felipe P Perez; David Bose; Bryan Maloney; Kwangsik Nho; Kavita Shah; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Long-term variability of inflammatory markers and associated factors in a population-based cohort.

Authors:  Scott D Nash; Karen J Cruickshanks; Ronald Klein; Barbara E K Klein; F Javier Nieto; Rick Chappell; Carla R Schubert; Michael Y Tsai
Journal:  J Am Geriatr Soc       Date:  2013-07-26       Impact factor: 5.562

4.  Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.

Authors:  Jeffrey R Crawford; Nicole L Bjorklund; Giulio Taglialatela; Richard H Gomer
Journal:  Neurochem Res       Date:  2011-12-29       Impact factor: 3.996

5.  Elevated Markers of Inflammation Are Associated With Longitudinal Changes in Brain Function in Older Adults.

Authors:  Kristen N Warren; Lori L Beason-Held; Olga Carlson; Josephine M Egan; Yang An; Jimit Doshi; Christos Davatzikos; Luigi Ferrucci; Susan M Resnick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-05-09       Impact factor: 6.053

6.  C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells.

Authors:  Haibiao Guo; Haitao Wang; Canmao Wang; Yufang Cheng; Zhengqiang Zou; Yiwen Li; Jingang Wu; Jiangping Xu
Journal:  J Mol Neurosci       Date:  2015-05-13       Impact factor: 3.444

7.  Mediterranean diet, Alzheimer disease, and vascular mediation.

Authors:  Nikolaos Scarmeas; Yaakov Stern; Richard Mayeux; Jose A Luchsinger
Journal:  Arch Neurol       Date:  2006-10-09

8.  The Alzheimer's Disease Exposome.

Authors:  Caleb E Finch; Alexander M Kulminski
Journal:  Alzheimers Dement       Date:  2019-09-10       Impact factor: 21.566

9.  Efflux transport of serum amyloid P component at the blood-brain barrier.

Authors:  Szilvia Veszelka; Judit Laszy; Tamás Pázmány; László Németh; Izabella Obál; László Fábián; Gábor Szabó; Csongor S Abrahám; Mária A Deli; Zoltán Urbányi
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

Review 10.  Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.

Authors:  Mary Iampietro; Tania Giovannetti; Reem Tarazi
Journal:  Neuropsychol Rev       Date:  2014-04-18       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.